PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES

Veure altres versions (1)

Dades bibliogràfiques
Autors principals:	Folgori, A, Barnes, E, Aston, S, Smith, K, Brown, A, Ambrosio, M, Ammendola, V, Bartiromo, M, Capone, S, Naddeo, M, Sparacino, A, Siani, L, Traboni, C, Colloca, S, Nicosia, A, Cortese, R, Klenerman, P
Format:	Conference item
Publicat:	2009

Ítems similars

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
per: Barnes, E, et al.
Publicat: (2009)

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC AND DURABLE T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
per: Barnes, E, et al.
Publicat: (2011)

A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
per: Kelly, C, et al.
Publicat: (2011)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
per: Capone, S, et al.
Publicat: (2010)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates.
per: Capone, S, et al.
Publicat: (2010)

IN VIVO ANTIGENIC TARGETS OF T CELLS INDUCED BY ADENOVIRAL VECTORED VACCINES IN PATIENTS WITH CHRONIC HCV INFECTION
per: Kelly, C, et al.
Publicat: (2012)

Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species.
per: Colloca, S, et al.
Publicat: (2012)

A highly immunogenic novel genetic vaccine against HCV
per: Del Sorbo, M, et al.
Publicat: (2012)

Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane
per: Alessandra Vitelli, et al.
Publicat: (2017-12-01)

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
per: Swadling, L, et al.
Publicat: (2014)

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.
per: Green, C, et al.
Publicat: (2015)

Highly immunogenic virally vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection
per: Swadling, L, et al.
Publicat: (2016)

Highly-immunogenic virally-vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection
per: Swadling, L, et al.
Publicat: (2016)

Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses.
per: Reyes-Sandoval, A, et al.
Publicat: (2010)

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection
per: Leo Swadling, et al.
Publicat: (2016-08-01)

Erratum: Prime-boost immunization with adenoviral and modified vaccinia virus ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses
per: Reyes-Sandoval, A, et al.
Publicat: (2011)

Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8(+) T-Cell Responses, (vol 78, pg 152, 2010)
per: Reyes-Sandoval, A, et al.
Publicat: (2011)

Immunogenicity and cross-reactivity of rhesus adenoviral vectors
per: Iampietro, M, et al.
Publicat: (2018)

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man
per: Barnes, E, et al.
Publicat: (2012)

Adenoviral vector vaccination induces a conserved program of CD8+ T cell memory differentiation in mouse and man
per: Bolinger, B, et al.
Publicat: (2015)

STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
per: Eriko Padron-Regalado, et al.
Publicat: (2022-08-01)

Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.
per: Draper, S, et al.
Publicat: (2010)

NEUTRALIZING ANTIBODY TITERS TO SIMIAN ADENOVIRAL VECTORS FOLLOWING ADCH63 ME-TRAP IMMUNIZATION IN HUMANS
per: Goodman, A, et al.
Publicat: (2009)

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
per: Reyes-Sandoval, A, et al.
Publicat: (2008)

Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
per: Lynda Coughlan
Publicat: (2020-05-01)

Immunogenicity of various variants of Ebola and Marburg virus glycoprotein genes in recombinant adenoviral vectors
per: T. A. Ozharovskaia, et al.
Publicat: (2024-10-01)

Adenoviral Vector Vaccination Induces a Conserved Program of CD8+ T Cell Memory Differentiation in Mouse and Man
per: Beatrice Bolinger, et al.
Publicat: (2015-11-01)

A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection
per: Felicity Hartnell, et al.
Publicat: (2019-01-01)

MAIT cell activation augments adenovirus vector vaccine immunogenicity
per: Provine, N, et al.
Publicat: (2021)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
per: Dicks, M, et al.
Publicat: (2011)

A novel vaccine strategy employing serologically different chimpanzee adenoviral vectors for the prevention of HIV-1 and HCV coinfection
per: Hartnell, F, et al.
Publicat: (2019)

Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans
per: Kelly, C, et al.
Publicat: (2016)

Correction: Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei
per: Reyes-Sandoval, A, et al.
Publicat: (2011)

Hepatitis Hide and Seek
per: Barnes, E, et al.
Publicat: (2012)

Chronic Hepatitis C Virus infection subverts vaccine induced T-cell immunity in humans.
per: Kelly, C, et al.
Publicat: (2016)

EVALUATION OF SIMIAN ADENOVIRAL VECTOR ADCH63 EXPRESSING MSP-1 AS A CANDIDATE BLOOD-STAGE MALARIA VACCINE
per: Goodman, A, et al.
Publicat: (2009)

Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.
per: Spencer, A, et al.
Publicat: (2014)

Correction: A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C.
per: Federico Napolitano, et al.
Publicat: (2021-04-01)

Prime-boost vectored malaria vaccines: progress and prospects.
per: Hill, A, et al.
Publicat: (2010)

Immunogenicity of a pre-erythrocytic-stage malaria insert ME-trap encoded by novel simian adenoviral vectors
per: Reyes-Sandoval, A, et al.
Publicat: (2005)